Detalhe da pesquisa
1.
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385281
2.
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces.
J Chem Inf Model
; 63(1): 343-353, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574607
3.
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Pediatr Blood Cancer
; 69(10): e29801, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656841
4.
Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma.
Int J Mol Sci
; 23(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077307
5.
Primary breast lymphoma of childhood: a case report and review of literature.
BMC Pediatr
; 21(1): 530, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847896
6.
Histology of pediatric classic Hodgkin lymphoma: From diagnosis to prognostic stratification.
Pediatr Blood Cancer
; 67(5): e28230, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134194
7.
Successful Treatment of an EBV-positive Diffuse Large B-Cell Lymphoma in a Patient With Trisomy 21.
J Pediatr Hematol Oncol
; 42(6): e472-e474, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045623
8.
MiR&moRe2: A Bioinformatics Tool to Characterize microRNAs and microRNA-Offset RNAs from Small RNA-Seq Data.
Int J Mol Sci
; 21(5)2020 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32143373
9.
Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma.
Int J Mol Sci
; 21(6)2020 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235718
10.
Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large-cell lymphoma treated with brentuximab vedotin: A case series.
Br J Haematol
; 204(1): 352-355, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822050
11.
MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
Proc Natl Acad Sci U S A
; 111(22): 8185-90, 2014 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24843176
12.
Paediatric non-Hodgkin lymphoma - perspectives in translational biology.
Br J Haematol
; 173(4): 617-24, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009921
13.
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Br J Haematol
; 175(3): 467-475, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27392319
14.
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
Blood
; 123(3): 334-7, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297868
15.
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma.
Haematologica
; 106(2): 610-613, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299901
16.
Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors.
Pediatr Hematol Oncol
; 38(1): 1-7, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621154
17.
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.
Br J Haematol
; 189(3): e108-e111, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080837
18.
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Br J Haematol
; 170(3): 367-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858645
19.
Pediatric IgG4-related lymphadenopathy: A rare condition associated with autoimmunity and lymphoproliferative disorders.
Pediatr Allergy Immunol
; 31(3): 332-336, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770465
20.
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
Am J Hematol
; 95(12): E319-E321, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808682